27 de mayo de 2027
FDA PDUFA target action date for obexelimab, a BLA from Zenas BioPharma. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
Calendario de Fechas de decisión PDUFA de la FDA